Published in Cancer Weekly, August 11th, 2009
"We found that the fraction of CD44v6+ cells is higher in estrogen receptor-positive carcinomas after...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.